出品|达摩财经老牌药企先声药业加速创新药转型,资本运作、人事变动密集落地。1月9日,先声药业(2096.HK)公告称,公司建议分拆子公司先声再明医药股份有限公司(下称“先声再明”)在联交所独立上市,同日,先声再明递表,联席保荐人为中金公司与摩根士丹利。先声再明成立于2020年,是先声药业旗下的抗肿瘤创新药平台。招股书显示,此次公司赴港上市募资,主要是为了获取资金加速创新管线开发、提升制造能力。...
Source Link出品|达摩财经老牌药企先声药业加速创新药转型,资本运作、人事变动密集落地。1月9日,先声药业(2096.HK)公告称,公司建议分拆子公司先声再明医药股份有限公司(下称“先声再明”)在联交所独立上市,同日,先声再明递表,联席保荐人为中金公司与摩根士丹利。先声再明成立于2020年,是先声药业旗下的抗肿瘤创新药平台。招股书显示,此次公司赴港上市募资,主要是为了获取资金加速创新管线开发、提升制造能力。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.